KIDS240719C40000
- 1.05
- 0.000.00%
OrthoPediatrics Newsroom
Does OrthoPediatrics (NASDAQ:KIDS) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
JMP Securities analyst David Turkaly maintains $OrthoPediatrics(KIDS.US)$ with a buy rating, and maintains the target price at $50.According to TipRanks data, the analyst has a success rate of 39.9% a
OrthoPediatrics Insiders Sold US$768k Of Shares Suggesting Hesitancy
OrthoPediatrics Corp. (NASDAQ:KIDS) shareholders might have a reason to worry after multiple insiders sold their shares over the last year. When evaluating insider transactions, knowing whether insi
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
WARSAW, Ind., June 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced
OrthoPediatrics Poised for Robust Growth With Strategic Acquisitions and Market Positioning: A Strong Buy Recommendation
OrthoPediatrics Corp Enhances Transparency With Investor Presentations
OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2024 Earnings Call Transcript
OrthoPediatrics (NASDAQ:KIDS) Adds US$121m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 41%
While it may not be enough for some shareholders, we think it is good to see the OrthoPediatrics Corp. (NASDAQ:KIDS) share price up 28% in a single quarter. But that cannot eclipse the less-than-im
OrthoPediatrics Price Target Raised to $38.00/Share From $35.00 by Truist Securities
OrthoPediatrics Price Target Raised to $38.00/Share From $35.00 by Truist Securities
OrthoPediatrics Is Maintained at Hold by Truist Securities
OrthoPediatrics Is Maintained at Hold by Truist Securities
Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $38
Truist Securities analyst Samuel Brodovsky maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target from $35 to $38.
OrthoPediatrics Corp (KIDS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
OrthoPediatrics | 10-Q: Quarterly report
Truist Securities Raises Price Target on OrthoPediatrics to $38 From $35, Maintains Hold Rating
OrthoPediatrics (KIDS) has an average outperform rating and price target range of $32 to $50, according to analysts polled by Capital IQ. Price: 35.00, Change: +1.40, Percent Change: +4.17
OrthoPediatrics Corp. (KIDS) Q1 2024 Earnings Call Transcript
OrthoPediatrics Corp. (KIDS) Q1 2024 Earnings Call Transcript
OrthoPediatrics Is Maintained at Buy by Needham
OrthoPediatrics Is Maintained at Buy by Needham
Needham Maintains Buy on OrthoPediatrics, Raises Price Target to $42
Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $37 to $42.
J.P. Morgan Securities Co., Ltd.: The OrthoPediatrics (KIDS.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $50.00.
J.P. Morgan Securities Co., Ltd.: The OrthoPediatrics (KIDS.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $50.00.
JMP Securities Reiterates Market Outperform on OrthoPediatrics, Maintains $50 Price Target
JMP Securities analyst David Turkaly reiterates OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and maintains $50 price target.
OrthoPediatrics: Strong Q1 Performance Prompts Buy Rating and Raised Price Target